These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16971775)

  • 1. [Diabetes and the metabolic syndrome].
    Yamauchi T; Kadowaki T
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):133-40. PubMed ID: 16971775
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucose metabolism in adipose tissue].
    Inoue A; Tobe K; Suzuki R; Kadowaki T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():673-80. PubMed ID: 12430302
    [No Abstract]   [Full Text] [Related]  

  • 3. [Candidate drugs for non-alcoholic steatohepatitis (NASH)].
    Terai S; Matsumoto T; Sakaida I
    Nihon Yakurigaku Zasshi; 2007 Apr; 129(4):271-5. PubMed ID: 17435339
    [No Abstract]   [Full Text] [Related]  

  • 4. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome?
    Rodríguez A; Catalán V; Gómez-Ambrosi J; Frühbeck G
    Curr Pharm Des; 2007; 13(21):2169-75. PubMed ID: 17627548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High fat diet and lipotoxicity].
    Inoue G; Koh M; Nakao K
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():626-31. PubMed ID: 12238109
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucose intolerance and resistin expression in rat offspring exposed to ethanol in utero: modulation by postnatal high-fat diet.
    Chen L; Nyomba BL
    Endocrinology; 2003 Feb; 144(2):500-8. PubMed ID: 12538610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the liver in the metabolic syndrome: evidence from animal models.
    Petruzzelli M; Lo Sasso G; Portincasa P; Palasciano G; Moschetta A
    Curr Pharm Des; 2007; 13(21):2199-207. PubMed ID: 17627553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High risk pathophysiology and the molecular mechanism of arteriosclerosis].
    Yamada N
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1667-75. PubMed ID: 17037299
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistin- and Obesity-associated metabolic diseases.
    Lazar MA
    Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adipokine and metabolic syndrome].
    Zhou LB; Chen MD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):840-4. PubMed ID: 17260479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue.
    Saravanan N; Haseeb A; Ehtesham NZ; Ghafoorunissa
    Eur J Endocrinol; 2005 Jul; 153(1):159-65. PubMed ID: 15998628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome.
    Delgado-Lista J; Perez-Martinez P; Garcia-Rios A; Phillips CM; Hall W; Gjelstad IM; Lairon D; Saris W; Kieć-Wilk B; Karlström B; Drevon CA; Defoort C; Blaak EE; Dembinska-Kieć A; Risérus U; Lovegrove JA; Roche HM; Lopez-Miranda J
    Nutr Metab Cardiovasc Dis; 2013 May; 23(5):417-23. PubMed ID: 22269963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
    Goralski KB; Sinal CJ
    Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.
    Haluzik MM; Lacinova Z; Dolinkova M; Haluzikova D; Housa D; Horinek A; Vernerova Z; Kumstyrova T; Haluzik M
    Endocrinology; 2006 Sep; 147(9):4517-24. PubMed ID: 16740970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of the GLUT4 gene: from PPAR-gamma and FOXO1 to FFA and inflammation.
    Armoni M; Harel C; Karnieli E
    Trends Endocrinol Metab; 2007 Apr; 18(3):100-7. PubMed ID: 17317207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of anthocyanins in the prevention and treatment of type 2 diabetes.
    Różańska D; Regulska-Ilow B
    Adv Clin Exp Med; 2018 Jan; 27(1):135-142. PubMed ID: 29521054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
    Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C.
    Wong SP; Huda M; English P; Bargiota A; Wilding JP; Johnson A; Corrall R; Pinkney JH
    Diabetologia; 2005 Dec; 48(12):2641-9. PubMed ID: 16320084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
    Graham TE; Yang Q; Blüher M; Hammarstedt A; Ciaraldi TP; Henry RR; Wason CJ; Oberbach A; Jansson PA; Smith U; Kahn BB
    N Engl J Med; 2006 Jun; 354(24):2552-63. PubMed ID: 16775236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue as an endocrine organ.
    Galic S; Oakhill JS; Steinberg GR
    Mol Cell Endocrinol; 2010 Mar; 316(2):129-39. PubMed ID: 19723556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.